NO20005879L - Tarm-beskyttelsesbelagt farmasöytisk blanding og fremgangsmåte for fremstilling - Google Patents

Tarm-beskyttelsesbelagt farmasöytisk blanding og fremgangsmåte for fremstilling

Info

Publication number
NO20005879L
NO20005879L NO20005879A NO20005879A NO20005879L NO 20005879 L NO20005879 L NO 20005879L NO 20005879 A NO20005879 A NO 20005879A NO 20005879 A NO20005879 A NO 20005879A NO 20005879 L NO20005879 L NO 20005879L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical composition
coated pharmaceutical
protective coated
intestinal protective
Prior art date
Application number
NO20005879A
Other languages
English (en)
Other versions
NO20005879D0 (no
NO322903B1 (no
Inventor
Ismat Ullah
Gary J Wiley
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22179393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005879(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20005879D0 publication Critical patent/NO20005879D0/no
Publication of NO20005879L publication Critical patent/NO20005879L/no
Publication of NO322903B1 publication Critical patent/NO322903B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005879A 1998-05-22 2000-11-21 Fremgangsmate for fremstilling av en farmasoytisk blanding av enterisk belagte sma kuler og farmasoytisk blanding fremstilt med fremgangsmaten NO322903B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8359798A 1998-05-22 1998-05-22
PCT/US1998/016128 WO1999061002A1 (en) 1998-05-22 1998-08-04 Enteric coated pharmaceutical composition and method of manufacturing

Publications (3)

Publication Number Publication Date
NO20005879D0 NO20005879D0 (no) 2000-11-21
NO20005879L true NO20005879L (no) 2001-01-18
NO322903B1 NO322903B1 (no) 2006-12-18

Family

ID=22179393

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20005879A NO322903B1 (no) 1998-05-22 2000-11-21 Fremgangsmate for fremstilling av en farmasoytisk blanding av enterisk belagte sma kuler og farmasoytisk blanding fremstilt med fremgangsmaten
NO20062106A NO20062106L (no) 1998-05-22 2006-05-10 Tarm-beskyttelsesbelagt farmasoytisk blanding og sfaeronisert kule

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20062106A NO20062106L (no) 1998-05-22 2006-05-10 Tarm-beskyttelsesbelagt farmasoytisk blanding og sfaeronisert kule

Country Status (40)

Country Link
US (2) US6224910B1 (no)
EP (1) EP1079809B1 (no)
JP (2) JP3798625B2 (no)
KR (1) KR100484299B1 (no)
CN (1) CN1149075C (no)
AP (1) AP1206A (no)
AR (1) AR017747A1 (no)
AT (2) ATE311859T1 (no)
AU (1) AU750911B2 (no)
BG (1) BG65398B1 (no)
BR (1) BR9815861A (no)
CA (1) CA2332922C (no)
CO (1) CO5070679A1 (no)
CY (1) CY1119543T1 (no)
CZ (1) CZ300497B6 (no)
DE (2) DE69832731T2 (no)
DK (2) DK1079809T3 (no)
DZ (1) DZ2797A1 (no)
EE (1) EE04926B1 (no)
ES (1) ES2165833T3 (no)
GE (1) GEP20033014B (no)
HK (1) HK1034461A1 (no)
HU (1) HU226491B1 (no)
ID (1) ID27031A (no)
IL (1) IL139274A (no)
LT (1) LT4843B (no)
LV (1) LV12602B (no)
MA (1) MA26636A1 (no)
NO (2) NO322903B1 (no)
NZ (1) NZ508194A (no)
OA (1) OA11512A (no)
PL (1) PL193294B1 (no)
RO (1) RO121674B1 (no)
RU (1) RU2197227C2 (no)
SK (1) SK284890B6 (no)
TN (1) TNSN99097A1 (no)
TR (1) TR200003373T2 (no)
UA (1) UA69413C2 (no)
WO (1) WO1999061002A1 (no)
ZA (1) ZA993090B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
CA2322641C (en) 1998-03-23 2010-02-16 General Mills, Inc. Encapsulation of components into edible products
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
EP1341529A2 (en) * 2000-11-10 2003-09-10 F. Hoffman-la Roche AG Hydrolytically unstable compositions
EP1380330B1 (en) * 2001-04-04 2008-06-04 Ngk Insulators, Ltd. Rain water treating device in combined sewage, and backwashing method therefor
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
US8658202B2 (en) * 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
BR0212951A (pt) * 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas
WO2003057195A1 (en) * 2002-01-11 2003-07-17 Athpharma Limited Pravastatin pharmaceutical formulations and methods of their use
EP1905431A1 (en) * 2002-01-11 2008-04-02 Circ Pharma Research and Development Limited Pravastatin pharmaceutical formulations and methods of their use
EP1477182A4 (en) * 2002-01-21 2009-05-27 Nrl Pharma Inc NEW ANALGETICS
EP1490029A4 (en) * 2002-03-22 2006-02-22 Ranbaxy Lab Ltd DRUG DELIVERY SYSTEM WITH CONTROLLED RELEASE OF PRAVASTATIN
US20040028737A1 (en) * 2002-08-12 2004-02-12 Kopran Research Laboratories Limited Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
JP2006503023A (ja) * 2002-09-03 2006-01-26 バイオヴェイル ラボラトリーズ インコーポレイテッド スタチン薬物の放出調節ための医薬品製剤および方法
US20040132806A1 (en) * 2002-09-03 2004-07-08 Jackie Butler Pravastatin pharmaceutical formulations and methods of their use
CA2520321A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
CN100415211C (zh) * 2003-07-03 2008-09-03 上海现代药物制剂工程研究中心 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法
US20050244490A1 (en) * 2003-12-09 2005-11-03 Michael Otto Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
PT1729797E (pt) * 2004-03-22 2008-12-17 Solvay Pharm Gmbh Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
WO2006054175A2 (en) * 2004-11-18 2006-05-26 Aurobindo Pharma Limited Stable dosage forms of acid labile drug
ES2306278T3 (es) * 2004-11-18 2008-11-01 Bristol-Myers Squibb Company Perla enterica recubierta que comprende ixabepilona.
US20060134214A1 (en) * 2004-11-18 2006-06-22 Ismat Ullah Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP1916995B2 (en) 2005-07-29 2022-06-29 Stichting Groningen Centre for Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
AU2006274835B2 (en) 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
ATE457719T2 (de) 2005-08-15 2010-03-15 Solvay Pharm Gmbh Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007072060A2 (en) * 2005-12-23 2007-06-28 Cipla Limited Particles comprising a core containing a hmg-coa reductase inhibitor and coated with a film
BRPI0707277B1 (pt) 2006-01-27 2021-07-13 The Regents Of The University Of California Composição, uso da mesma,e , formulação famacêutica
WO2007109244A2 (en) * 2006-03-21 2007-09-27 Morehouse School Of Medicine Novel nanoparticles for delivery of active agents
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
ES2331501B1 (es) * 2007-11-14 2010-10-21 Blanver Farmoquimica, Ltda Composicion farmaceutica solida de didanosina.
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EA021758B1 (ru) 2008-04-24 2015-08-31 Бристол-Маерс Сквибб Компани Способ лечения болезни альцгеймера
AU2009322285B2 (en) * 2008-12-03 2016-07-28 Bausch Health Ireland Limited Formulations of guanylate cyclase C agonists and methods of use
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
WO2012037380A2 (en) 2010-09-15 2012-03-22 Synergy Pharmaceuticals Inc. Formulations of guanylate cyclase c agonists and methods of use
GB2484929A (en) 2010-10-25 2012-05-02 Maria Christiana Peter Geraedts An edible product including plant protein
KR20120135063A (ko) * 2011-06-01 2012-12-12 닛토덴코 가부시키가이샤 입자 제제 및 그 제조 방법
US10117447B1 (en) * 2013-03-15 2018-11-06 The United States Of America, As Represented By The Secretary Of Agriculture Extrusion of high density hydroxypropylmethylcellulose edible flexible gels
TWI649100B (zh) * 2013-06-17 2019-02-01 地平線罕見醫學製藥有限責任公司 延遲釋放型半胱胺珠粒調配物，以及其製備及使用方法
CN104758180A (zh) * 2014-01-06 2015-07-08 山东诚创医药技术开发有限公司 一种复方制剂胶囊的二次填充方法
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
PE20181295A1 (es) 2015-09-01 2018-08-07 First Wave Bio Inc Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala
US10143665B2 (en) 2015-11-17 2018-12-04 Horizon Orphan Llc Methods for storing cysteamine formulations and related methods of treatment
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
RU2670447C2 (ru) * 2016-11-17 2018-10-23 Общество с ограниченной ответственностью "Изварино Фарма" Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения
AU2018272076A1 (en) 2017-05-26 2019-12-12 Animal Microbiome Analytics, Inc. Products and methods for therapeutic administration of microorganisms to non-human animals
KR20210043779A (ko) * 2019-10-11 2021-04-22 넨시스(주) 판크레아틴 장용코팅 펠릿 제조방법
US20230102999A1 (en) 2020-01-10 2023-03-30 First Wave Bio, Inc. Deuterated niclosamide
US20230190684A1 (en) 2020-03-16 2023-06-22 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809918A (en) 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
DE2010416B2 (de) 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
ZA822995B (en) 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4704295A (en) 1983-09-19 1987-11-03 Colorcon, Inc. Enteric film-coating compositions
US4556552A (en) 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
US4728512A (en) 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
WO1987001284A1 (en) 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
US5254539A (en) 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US4975283A (en) 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4775536A (en) 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4794001A (en) 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
US4808413A (en) 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
JP2643222B2 (ja) 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US4925675A (en) 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US5026559A (en) 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US5175003A (en) 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5350584A (en) 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
EP0653935B1 (en) 1992-08-05 2002-05-08 F.H. FAULDING & CO. LIMITED Pelletised pharmaceutical composition
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
IT1265074B1 (it) * 1993-05-18 1996-10-30 Istituto Biochimico Italiano Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare
US5536507A (en) 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5686106A (en) 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
US5789014A (en) 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I

Also Published As

Publication number Publication date
HUP0101714A3 (en) 2002-10-28
AU8685498A (en) 1999-12-13
MA26636A1 (fr) 2004-12-20
ATE311859T1 (de) 2005-12-15
WO1999061002A1 (en) 1999-12-02
RU2197227C2 (ru) 2003-01-27
EE200000680A (et) 2002-10-15
NO20005879D0 (no) 2000-11-21
NO20062106L (no) 1999-11-23
DK1079809T3 (da) 2006-02-20
EP1079809B1 (en) 2005-12-07
JP2006022115A (ja) 2006-01-26
KR20010043736A (ko) 2001-05-25
AP1206A (en) 2003-09-18
OA11512A (en) 2004-02-03
RO121674B1 (ro) 2008-02-28
CZ20004362A3 (en) 2001-05-16
CN1294509A (zh) 2001-05-09
DE1079809T1 (de) 2002-08-22
NZ508194A (en) 2003-07-25
US6224910B1 (en) 2001-05-01
BG105061A (en) 2001-07-31
PL193294B1 (pl) 2007-01-31
AR017747A1 (es) 2001-10-24
AT6311U1 (de) 2003-08-25
JP3798625B2 (ja) 2006-07-19
ES2165833T3 (es) 2006-05-16
UA69413C2 (uk) 2004-09-15
DE69832731D1 (de) 2006-01-12
SK16302000A3 (sk) 2001-08-06
DZ2797A1 (fr) 2003-12-01
CA2332922A1 (en) 1999-12-02
ZA993090B (en) 2000-11-06
EP1079809A1 (en) 2001-03-07
US20010005716A1 (en) 2001-06-28
CZ300497B6 (cs) 2009-06-03
IL139274A0 (en) 2001-11-25
TNSN99097A1 (fr) 2005-11-10
AU750911B2 (en) 2002-08-01
LT4843B (lt) 2001-09-25
LV12602A (en) 2001-01-20
TR200003373T2 (tr) 2001-03-21
EP1079809A4 (en) 2001-11-07
KR100484299B1 (ko) 2005-04-20
PL344259A1 (en) 2001-10-22
JP2002516268A (ja) 2002-06-04
CY1119543T1 (el) 2018-04-04
AP2000001988A0 (en) 2000-12-31
DK200200229U3 (da) 2003-01-24
ES2165833T1 (es) 2002-04-01
BG65398B1 (bg) 2008-06-30
CO5070679A1 (es) 2001-08-28
BR9815861A (pt) 2001-01-16
CN1149075C (zh) 2004-05-12
LT2000105A (en) 2001-04-25
LV12602B (en) 2001-07-20
GEP20033014B (en) 2003-07-25
CA2332922C (en) 2008-02-12
ID27031A (id) 2001-02-22
IL139274A (en) 2004-12-15
HU226491B1 (en) 2009-03-02
EE04926B1 (et) 2007-12-17
HUP0101714A2 (hu) 2002-01-28
NO322903B1 (no) 2006-12-18
SK284890B6 (sk) 2006-02-02
DE69832731T2 (de) 2006-09-14
HK1034461A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
NO20005879L (no) Tarm-beskyttelsesbelagt farmasöytisk blanding og fremgangsmåte for fremstilling
NO20010260L (no) Tarmbeskyttelsesbelagt farmasøytisk tablett og fremgangsmÕte for fremstilling
NO20004741D0 (no) Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO20015888D0 (no) Implanterbare gelpreparater og fremgangsmåte for fremstilling
NO993519D0 (no) Fenofibrat farmasoeytisk blanding som har hoey biotilgjengelighet og fremgangsmåte for fremstilling avden
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
EE03976B1 (et) Erütromütsiinid ja nende valmistamise meetod
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
NO20000932D0 (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
NO993288D0 (no) Antimikrobiell handske og fremgangsmÕte for fremstilling derav
PL312270A1 (en) Novel derivatives of indolopiperidine, method of obtaining them and pharmaceutical preparation and method of obtaining same
NO20003070D0 (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
NO982329D0 (no) Kreftvaksine og fremgangsmÕte for fremstilling derav
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
DK0702344T3 (da) Etiketkontinuum og fremgangsmåde til fremstilling deraf
IL123927A (en) Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
NO962914L (no) Varmeherdende pulverbeleggingssystem og fremgangsmåte for fremstilling derav
HUP0001773A3 (en) Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK1K Patent expired